Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor vaccine based on extracellular vesicles derived from γδ‐T cells exerts dual antitumor activities
Xiwei Wang, Yanmei Zhang, Yuet Chung, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 9
Open Access | Times Cited: 14

Showing 14 citing articles:

The Discovery of Extracellular Vesicles and Their Emergence as a Next-Generation Therapy
Alin Rai, Bethany Claridge, Jonathan Lozano, et al.
Circulation Research (2024) Vol. 135, Iss. 1, pp. 198-221
Closed Access | Times Cited: 19
Gamma/delta T cells as cellular vehicles for anti-tumor immunity
Chelsia Qiuxia Wang, Pei Yu Lim, Andy Hee‐Meng Tan
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 13
Photosensitive Hybrid γδ-T Exosomes for Targeted Cancer Photoimmunotherapy
Yifan Gao, Jinzhao Liu, Meicen Wu, et al.
ACS Nano (2025)
Open Access | Times Cited: 1
Immunocytes interact directly with cancer cells in the tumor microenvironment: one coin with two sides and future perspectives
Zhiyi Ye, Pu Cheng, Qi Huang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Extracellular vesicles-based vaccines: Emerging immunotherapies against cancer
Yuhua Meng, Zhimeng Yao, Xiurong Ke, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 438-459
Open Access | Times Cited: 5
Extracellular Vesicle‐Based Antitumor Nanomedicines
Mingfeng Li, Yanfei Liu, Fei Liu, et al.
Advanced Healthcare Materials (2025)
Closed Access
The antiviral potential of Vγ9Vδ2 T cells: Therapeutic implications for immunocompromised adult and pediatric hosts
Veronica Bordoni, Federica Guarracino, Alessandro Lorusso, et al.
International review of cell and molecular biology (2025)
Closed Access
Dendritic Cell Derived‐Extracellular Vesicles Engineered to Express Interleukin‐12 and Anti‐CTLA‐4 on Their Surface for Combinational Cancer Immunotherapy
Jiangbin Chen, Qi Tan, Zimo Yang, et al.
Journal of Extracellular Vesicles (2025) Vol. 14, Iss. 4
Open Access
Strategies for small extracellular vesicle-based cancer immunotherapy
Yundi Chen, Shasha Tang, Fengfeng Cai, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 3
Immunotherapy revolutionizing brain metastatic cancer treatment: personalized strategies for transformative outcomes
Ting Li, Shichen Sun, Yubing Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Advancements in melanoma immunotherapy: the emergence of Extracellular Vesicle Vaccines
Guijuan He, Yichuan Li, Yuyang Zeng, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Albumin tailoring molecular rotation and electrophilicity of a GSH-depleting radiosensitizer for potentiating ferroptosis-mediated radioimmunotherapy
Mingquan Gao, Xie Huang, Zifei Wu, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153595-153595
Closed Access | Times Cited: 2
Applications of plant‐derived extracellular vesicles in medicine
Yawen Zhu, Junqi Zhao, Haoran Ding, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 2
Extracellular vesicles derived from immune cells: Role in tumor therapy
Yuanyuan Shi, Fei Yao, Yin Yao, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112150-112150
Closed Access | Times Cited: 1
Page 1

Scroll to top